Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC
It’s a medical marijuana company helping over 80,000 patients and you may have never heard of it. Jim Cramer looks into Trulieve and what it can tell us about the…
How the coronavirus outbreak is hitting legal cannabis companies
CNBC’s Jane Wells reports on how the coronavirus outbreak is hitting legal cannabis companies. For access to live and exclusive video from CNBC subscribe to CNBC PRO: /> Subscribe to…
Martha Stewart on her line of CBD products
Cannabis sales are booming and MKM Partners is telling investors to buy shares of Canopy Growth. It upgraded the stock a a buy earlier this week, citing the Martha Stewart…
Amazon will no longer test job seekers for marijuana
Amazon says it will no longer require job seekers to submit to drug testing for marijuana, though it will still test workers for other illegal substances. CNBC’s “Squawk Box” crew…
Top cannabis ETF manager on key industry trends to watch
Tim Seymour of Seymour Asset Management, Christian Magoon of Amplify ETFs and Matt Hougan of Bitwise Asset Management discuss 2021’s cannabis craze with CNBC’s Bob Pisani. For access to live…
Cannabis stocks rally as U.S. lawmakers mull federal legislation
Are pot stocks a safe bet with the SAFE Banking Act gaining momentum? CNBC’s Frank Holland joins ‘Squawk Box’ to break down the sector. For access to live and exclusive…
Green Thumb CEO on what’s next for the cannabis industry
Ben Kovler, Green Thumb Industries CEO, on his company’s earnings and potential cannabis regulations from the government. With CNBC’s Courtney Reagan and the Fast Money traders, Guy Adami, Karen Finerman,…